ArticleTheranostics2020

Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.

Xiaomeng Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.